Your browser doesn't support javascript.
loading
Feasibility and preliminary efficacy of a novel web-based physical activity intervention in adults with overweight/obesity: A pilot randomized controlled trial.
Kariuki, Jacob K; Sereika, Susan; Erickson, Kirk; Burke, Lora E; Kriska, Andrea; Cheng, Jessica; Milton, Heather; Hirshfield, Sabina; Ogutu, David; Gibbs, Bethany.
Afiliación
  • Kariuki JK; Emory University, GA, USA. Electronic address: Jacob.Kariuki@emory.edu.
  • Sereika S; University of Pittsburgh, PA, USA.
  • Erickson K; AdventHealth Research Institute, FL, USA.
  • Burke LE; University of Pittsburgh, PA, USA.
  • Kriska A; University of Pittsburgh, PA, USA.
  • Cheng J; Harvard University T. H. Chan School of Public Health, MA, USA.
  • Milton H; NYU Langone Health, NY, USA.
  • Hirshfield S; SUNY Downstate Medical Center, NY, USA.
  • Ogutu D; Ritiko Consulting, TN, USA.
  • Gibbs B; University of West Virginia, WV, USA.
Contemp Clin Trials ; 133: 107318, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37625586
ABSTRACT

BACKGROUND:

Only 14% of adults with obesity attain federal guidelines for physical activity (PA), but few interventions address obesity-specific barriers to PA. We designed the web-based Physical Activity for The Heart (PATH) intervention to address this gap.

PURPOSE:

Test the feasibility and preliminary efficacy of PATH for promoting PA and reducing cardiovascular disease (CVD) risk in adults with overweight/obesity.

METHODS:

In a 12-week pilot RCT, participants were randomized to PATH (n = 41) or wait-list control (n = 41) groups. Treatment group received access to PATH and met twice/month with a remote coach. The control group received a self-help PA guide and newsletters on general health. Moderate-to-vigorous PA (MVPA) was assessed via Actigraph-GT3X, steps via Fitbit Charge 2™, weight via smart scale, blood pressure (BP) via Omron BP device, and lipids/HbAIC via dry blood spot. Linear mixed modeling examined between- and within-group differences in PA and CVD risk.

RESULTS:

The sample (N = 82) was on average 55.9 ± 8.2 years old; mean BMI 35.5 ± 6.2 kg/m2; 57.3% white and 80.5% female. Recruitment lasted 6-months, and 12-week retention was 96.3%. Treatment group accessed PATH ≥twice/week (92.1%), spent ≥10 min/visit (89.5%) and thought the site was culturally appropriate (79%). At 12 wks, the PATH group had greater mean changes in weekly MVPA (+58.9 vs. +0.9 min, p = .024) and daily steps (+1246.4 vs. -64.2 steps, p = .002) compared to the control group. Also, the PATH group improved in weight, BMI, body fat, waist circumference, and BP (p < .05).

CONCLUSION:

The PATH intervention is feasible/acceptable and demonstrated preliminary efficacy for promoting PA among adults with overweight/obesity.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2023 Tipo del documento: Article
...